IMJUDO 20 mg/ml concentrate for solution for infusion | medicines.ie

Company: AstraZeneca Pharmaceuticals (Ireland) DAC
Active Ingredient: Tremelimumab
Strength: Tremelimumab: 25 mg
Dosage Form: Concentrate for solution for infusion
Legal Category: A - prescription, may not be renewed
Last Updated: 25/09/2026

Loading the document

AstraZeneca Pharmaceuticals (Ireland) DAC

College Business and Technology Park, Blanchardstown Road North, Dublin 15, D15 R925, D15 R925 Dublin

Website: https://contactazmedical.astrazeneca.com
Telephone: +3531800800899
Email: mipqc.ireland@astrazeneca.com